The aim of this study was to assess the relationship between serum vitamin B12 levels and clinical, histological features of CHC and to analyze its capacity as a predictor for sustained virus clearance upon a combination therapy with Peg-IFN-α and RBV. The gene discussed is IFNA2; the disease is cryohydrocytosis.